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Abstract Internalisation of the human pathogen Yersinia pseu-
dotuberculosis via interaction of bacterial invasin with host L1
integrins depends on the actin cytoskeleton and involves Src
family kinases, focal adhesion kinase, p130Crk-associated sub-
strate, proline-rich tyrosine kinase 2, Rac, Arp 2/3 complex and
WASP family members. We show here that Rho GTPases are
regulated by the microtubule system during bacterial uptake.
Interfering with microtubule organisation using nocodazole or
paclitaxel suppressed uptake by HeLa cells. The nocodazole
e¡ect on microtubule depolymerisation was partially inhibited
through overexpression of Rac, Cdc42, RhoG or RhoA and
completely prevented by expression of Vav2. This suggests
that microtubules in£uence Rho GTPases during invasin-medi-
ated phagocytosis and in the absence of functional microtubules
Vav2 can mimic their e¡ect on one, or more, of the Rho family
GTPases. Lastly, overexpression of p50 dynamitin partially in-
hibited bacterial uptake and this e¡ect was also blocked by co-
expression of Vav2, thus further implicating this guanine nucle-
otide exchange factor in activating Rho GTPases for internal-
isation during loss of microtubule function.
1 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Entry of the bacterial pathogen Yersinia pseudotuberculosis
into non-professional phagocytic cells is initiated subsequent
to the binding of the bacterial surface protein invasin to host
cell L1 integrins [1]. While much is known regarding the trans-
duction pathways that govern membrane remodelling during
phagocytosis through FcQ receptor (FcQR) and complement
receptor 3, the molecular machinery required for invasin-pro-
moted internalisation via L1 integrins is only beginning to be
understood. We, and others, have shown a requirement for
actin, a subset of Rho GTPases and WASP family proteins
during invasin-stimulated internalisation of Yersinia by non-
phagocytic cells [2^4] as well as professional phagocytes [5].
These proteins have been shown to regulate various cellular
processes [6^10]. In this current study, a possible additional
role for microtubules during Yersinia uptake was investigated
given the recent observations that co-ordination of signals
between the actin and microtubule cytoskeletons is mediated
through Rho family GTPases during cell locomotion [11^13].
Invasion of cultured cells by certain pathogenic bacteria is
known to be signi¢cantly a¡ected by drug-induced disruption
of the microtubule system [14^17]. The role of microtubules in
bacterial invasion has not been clari¢ed, some bacteria how-
ever can interact with microtubules and possibly move intra-
cellularly via a dynein-dependent mechanism, e.g. Campylo-
bacter jejuni and Orientia tsutsugamushi [18,19]. More recently
it was demonstrated that the Shigella £exneri VirA e¡ector
protein, which is essential for cell entry, interacts with tubulin
dimers leading to destabilisation of microtubules [20]. Here we
show that invasin-stimulated uptake of bacteria is abrogated
when microtubule organisation is perturbed through use of
microtubule-disrupting drugs. However, overexpression of
Rho GTPase family members and their regulators can, to a
large extent, prevent this drug-induced inhibition. Hence in-
vasin-promoted internalisation involves interplay between the
microtubule and actin cytoskeletons, which is mediated by
Rho GTPases.
2. Materials and methods
2.1. Transfection, bacterial infection and immuno£uorescence analyses
The pCB6-EGFP-Cdc42 constructs have been described [4], cloning
of Rac1 and RhoA constructs into the pCB6-EGFP expression vector
will be reported elsewhere. Transfection of HeLa cells and subsequent
infection followed by immuno£uorescence analysis of bacterial inter-
nalisation was performed as previously described [4] except that in-
fection was carried out for 10 min. Numbers of extracellular and total
cell-associated bacteria were counted for 40 random transfected and
untransfected cells per coverslip.
For the normalised uptake graphs, internalisation of bacteria by
drug-treated, transfected cells is normalised to that of untreated,
transfected cells. Likewise, uptake by drug-treated, untransfected cells
is normalised to that of untreated, untransfected cells. Subcellular
localisation of tubulin was detected with an anti-K-tubulin monoclo-
nal antibody, B-5-1-2 (Sigma-Aldrich, Deisenhofen, Germany), fol-
lowed by rhodamine anti-mouse IgG (Jackson Immunoresearch,
West Grove, PA, USA), total Yersiniae were stained with rabbit
anti-Yersinia antiserum followed by FITC-conjugated swine anti-rab-
bit immunoglobulin (Dako, Glostrup, Denmark) and the cell nuclei
were stained with DAPI (Sigma-Aldrich). For the nocodazole and
paclitaxel titration assays the infected untransfected cells were stained
as described before [4] with the modi¢cation that AMCA-conjugated
donkey anti-rabbit IgG (Jackson Immunoresearch) was used to stain
total bacteria and Alexa 488 (Molecular Probes, Eugene, OR, USA)
was used to label F-actin. Coverslips were mounted in Mowiol (Cal-
biochem, La Jolla, CA, USA). Images were collected with a Zeiss
Axiophot microscope (Carl Zeiss AB, Oberkochen, Germany) using
a C4742-95 SC Matrix digital camera and Twain 32 imaging software
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(Hamamatsu Photonics, Germany) and processed using Adobe soft-
ware (Adobe, San Jose, CA, USA).
2.2. Quanti¢cation of cellular microtubule content by £ow cytometry
This was carried out by a method modi¢ed from Holmfeldt et al.
[21]: HeLa cells were seeded at a density of 5U104 cells per well in a
24-well tissue culture plate. After 15 h the cells were treated with
nocodazole or paclitaxel (Sigma-Aldrich) for 1 h. Then the medium
was aspirated and soluble tubulin was extracted with a microtubule-
stabilising bu¡er, containing 4 WM paclitaxel and 0.05% saponin.
Subsequently the cells were detached from the substratum by gentle
scraping and then ¢xed in 2% paraformaldehyde. Cells were washed,
and tubulin was labelled with anti-K-tubulin monoclonal antibody, B-
5-1-2 (Sigma-Aldrich), followed by FITC rabbit anti-mouse immuno-
globulin (Dako). When staining green £uorescent protein (GFP)-
transfected cells Cy5 donkey anti-mouse IgG (Jackson Immunore-
search) was used instead of the FITC secondary antibody. Propidium
iodide solution was used to stain the nuclear content. Finally the cells
were subjected to £ow cytometry on a FACs-calibur in combination
with Cell Quest software (Becton Dickinson, Mountain View, CA,
USA).
3. Results and discussion
3.1. Perturbing microtubule organisation inhibits entry of
Yersinia into HeLa cells
To determine whether the microtubule cytoskeleton is re-
quired during invasin-promoted uptake we examined the con-
sequence of depolymerising microtubules with nocodazole on
the uptake of the avirulent strain of Y. pseudotuberculosis
(YPIII) by HeLa cells. Immuno£uorescent analysis of bacte-
rial internalisation revealed that Yersinia uptake was inhibited
by nocodazole in a dose-responsive fashion (Fig. 1B). A re-
duction in uptake was also observed when cells were treated
with the microtubule-disrupting agent vinblastine (data not
shown). Examination of treated HeLa cells by £ow cytometry
con¢rmed that increasing concentrations of nocodazole re-
sulted in a corresponding decrease in microtubule polymer
mass (Fig. 1B). In addition, epi£uorescence examination of
cells incubated with an K-tubulin antibody showed the e¡ect
of nocodazole on the arrangement of microtubules, where the
higher drug concentrations caused a visible reduction in the
number of polymerised microtubules (Fig. 1A). To ascertain
whether it was microtubule dynamics, or the presence of poly-
mer, that was involved in Yersinia uptake we also examined
the e¡ect of the microtubule stabiliser paclitaxel. We found
that this treatment, which caused an increase in the total
cellular content of microtubules, also resulted in a dose-de-
pendent reduction in Yersinia uptake (Fig. 1B). At low con-
centrations (9 100 nM) of either drug, we expect microtubule
dynamics to be in£uenced, whereas at the higher concentra-
tion the gross organisation of microtubules is also a¡ected
[22^24]. The relatively small e¡ects on bacterial uptake at
low concentrations compared to the more prominent blocking
at higher concentrations indicate that while dynamic behav-
iour cannot be completely ruled out it is mostly microtubule
function and organisation that is required for e⁄cient inter-
nalisation of Yersinia.
3.2. Rho family GTPases, and their upstream regulators, can
prevent nocodazole-induced blocking of uptake
How is the microtubule cytoskeleton linked to Yersinia up-
take? Recent reports have shown a coupling between Rho
GTPases and the microtubule system [25,26]. Our previous
observations have shown that Yersinia uptake involves
Rac1, a known regulator of protrusive events [27], which
can also bind tubulin [28]. Rac as well as Cdc42 can activate
PAK, which in turn inactivates the microtubule destabiliser
Op18, promoting polymer growth [25]. In addition, Rac and
Cdc42 have been shown to interact with microtubules through
a common e¡ector, IQ-GAP, which binds CLIP-170, a micro-
tubule-associated protein that is recruited to the plus ends of
polymerising microtubules [26]. Given these observations, we
examined whether expression of constitutively activated var-
iants of Rac or Cdc42 (GFP-RacL61 and GFP-Cdc42L61
respectively), would a¡ect Yersinia uptake in nocodazole-
treated HeLa cells. We found that the activated variants of
either Rac or Cdc42 partially rescued the inhibiting e¡ect of
nocodazole (Fig. 2B). It was also clear that the previously
reported recruitment of GFP-RacL61 and GFP-Cdc42L61
to internalised Yersinia [4] was una¡ected by nocodazole
(Fig. 2A and data not shown). Expression of dominant neg-
ative GFP-RacN17 and GFP-Cdc42N17 neither further inhib-
ited nor promoted uptake of Yersinia in the nocodazole-
treated cells although they were recruited to the few bacteria
that were internalised by these cells (Supplementary data1 and
data not shown). Interestingly, although activated Rac or
Cdc42 rescued bacterial uptake there were no appreciable dif-
ferences in the amount of polymerised microtubules in trans-
fected compared to untransfected nocodazole-treated cells
(Fig. 2B). This suggests that the rescue of uptake by expres-
sion of activated Rac or Cdc42 is not mediated through an
e¡ect on the microtubule cytoskeleton. Rather it is the micro-
tubule organisation that a¡ects Rho GTPases, thus promoting
bacterial uptake by a¡ecting the actin cytoskeleton. Similarly,
Waterman-Storer and coworkers have shown that microtu-
bule growth leads to activation of Rac, promoting lamellipo-
dial formation [29]. Their work, however, indicated involve-
ment of microtubule dynamics, whereas our work with
bacterial uptake is more consistent with an e¡ect of gross
organisation of microtubules rather than dynamics.
Given that Rac and Cdc42 partially rescued the inhibitory
e¡ect of nocodazole on Yersinia uptake we wondered whether
an upstream guanine nucleotide exchange factor (GEF) might
Fig. 1. Drugs that interfere with microtubule dynamics block invasin-promoted internalisation of Yersinia. A: Immuno£uorescence analysis of
HeLa cells treated with nocodazole 30 min prior to infection with YPIII. Cells are stained for K-tubulin (left panel) and the nucleus is stained
with DAPI (right panel). Yersiniae are stained with an anti-Yersinia antiserum (centre panel). Scale bar, 5 Wm, indicated in lower right corner.
B: Determination of YPIII uptake and microtubule polymer content in nocodazole- and paclitaxel-treated HeLa cells. Cells were pretreated
with increasing concentrations of the drugs for 30 min prior to infection. Each drug was present throughout infection. Results are the
meanTS.D. of ¢ve separate experiments. Subsequent to nocodazole/paclitaxel treatment HeLa cells were extracted, ¢xed and stained with an
K-tubulin antibody and propidium iodide. Total polymerised microtubule content was then assessed by £ow cytometry. The data obtained for
untreated cells have been normalised to the value of the steady-state level of tubulin, that is 76.5% in HeLa cells [48]. Results are representative
of the meanTS.E.M. of duplicate samples from two experiments.
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have a role in this process. Vav family proteins are GEFs for
Rho family GTPases [30^34], involved in cell spreading and
protrusive events [35,36]. Hitherto reported data are con£ict-
ing as to which subsets of Rho family GTPases are activated
by Vav [33,34,37], however, for FcQR-mediated phagocytosis
in macrophages Vav has been shown to regulate activation
of Rac but not Cdc42 [38]. Nevertheless, overexpression
of an activated variant of the ubiquitous family member
Vav2, v184N-Vav2-GFP, or an inactive variant, C-terminal
Vav2-GFP [34], had little e¡ect on bacterial uptake levels
(91.3 T 10.7% and 95.8T 7.5% respectively, n=7 for both).
Both proteins were weakly recruited to internalised bacteria,
although for the activated variant this localisation became
more apparent in the presence of nocodazole (Fig. 3A and
data not shown). In addition, v184N-Vav2-GFP localised
more intensely to the plasma membrane in drug-treated cells
and co-stained with tubulin in these discrete areas (Supple-
mentary data1), which may re£ect association of Vav2 with
tubulin. Interestingly, expression of v184N-Vav2-GFP com-
pletely rescued the nocodazole e¡ect on uptake of Yersinia,
Fig. 2. Activated Rac or Cdc42 partially rescues nocodazole-mediated inhibition of uptake. A: Immuno£uorescence of Yersinia uptake in HeLa
cells transfected with GFP-RacL61 or GFP-Cdc42L61 and treated with increasing nocodazole prior to infection. Shown are localisation of the
GFP proteins, total cell-associated bacteria and extracellular bacteria. Arrowheads indicate internalised bacteria. Scale bar, 5 Wm. B: Determi-
nation of YPIII uptake and microtubule polymerisation in nocodazole-treated HeLa cells transfected with GFP-RacL61 or GFP-Cdc42L61
(¢lled bars) or untransfected (open bars). Results are the meanTS.D. of ¢ve separate experiments for the uptake analysis and meanTS.D. of
duplicate samples from one experiment for the £ow cytometry analysis.
FEBS 26838 19-12-02 Cyaan Magenta Geel Zwart
K. McGee et al./FEBS Letters 533 (2003) 35^4138
which contrasts with the partial e¡ects of activated Rac or
Cdc42 (compare Fig. 2B with Fig. 3B). Expression of C-ter-
minal Vav2-GFP had no signi¢cant rescue e¡ect (Supplemen-
tary data1). The di¡erences in rescue e⁄ciency of Yersinia
uptake in nocodazole-treated cells by expressing Cdc42, Rac
or Vav2 would suggest that Vav2 most likely activates both
Rac and Cdc42 and possibly other additional GTPases. This
is consistent with our previous observation that toxin B com-
pletely inhibits Yersinia uptake whereas dominant negative
Rac causes partial inhibition [4]. Flow cytometry analyses of
cells revealed that expression of v184N-Vav2-GFP only mod-
estly a¡ected microtubule polymerisation, thus further sub-
Fig. 3. Activated Vav2 prevents nocodazole-mediated suppression of
uptake. A: Immuno£uorescence analysis of Yersinia uptake in HeLa
cells transfected with v184N-Vav2-GFP and pretreated with nocoda-
zole prior to infection. Shown are localisation of v184N-Vav2-GFP,
total cell-associated bacteria and extracellular bacteria. Arrowheads
indicate internalised bacteria. Scale bar, 5 Wm. B: Determination of
YPIII uptake and microtubule polymerisation in nocodazole-treated
HeLa cells transfected with v184N-Vav2-GFP (¢lled bars) or un-
transfected (open bars). Results are the meanTS.D. of four separate
experiments for the uptake analysis and meanTS.D. of duplicate
samples from one experiment for the £ow cytometry analysis. Fig. 4. Activated RhoG partially rescues nocodazole-mediated inhi-
bition of uptake. A: Immuno£uorescence analyses of Yersinia up-
take in HeLa cells transfected with GFP-RhoGV12 and treated with
increasing concentrations of nocodazole prior to infection. Shown
are localisation of GFP-RhoGV12, total cell-associated bacteria and
extracellular bacteria. Arrowheads indicate internalised bacteria.
Scale bar, 5 Wm. B: Determination of YPIII uptake by nocodazole-
treated HeLa cells transfected with GFP-RhoGV12 or GFP-
RhoGN17 (¢lled bars) or untransfected (open bars). Results are the
meanTS.D. of four separate experiments.
FEBS 26838 19-12-02 Cyaan Magenta Geel Zwart
K. McGee et al./FEBS Letters 533 (2003) 35^41 39
stantiating the proposal that this GEF does not regulate mi-
crotubules themselves but rather governs GTPase activity
(Fig. 3B).
RhoG, which is a widely expressed GTPase, can activate
Rac- and Cdc42-dependent ru¥es, lamellipodia and ¢lopodia
formation [39]. Furthermore, depolymerisation of microtu-
bules by nocodazole results in the loss of RhoG-induced
Rac and Cdc42 morphological e¡ects [39]. Given these obser-
vations we examined the e¡ect of expressing activated RhoG
(GFP-RhoGV12) and dominant negative RhoG (GFP-
RhoGN17) on invasin-mediated phagocytosis of Yersinia. Ex-
pression of GFP-RhoGV12 was found to slightly stimulate
uptake levels (111.8 T 11.6%, n=6). We have previously seen
a similar level of stimulation of bacterial uptake when acti-
vated Rac (GFP-RacL61) is expressed [4]. However, in con-
trast to that of dominant negative RacN17 [4], we found that
GFP-RhoGN17 had no inhibitory e¡ect on Yersinia uptake
(96.4 T 16.2%, n=6). The ability of RhoGV12 to rescue bac-
terial uptake in nocodazole-treated cells was however compa-
rable to that seen with activated Rac or Cdc42, but not the
sum of the two (compare Fig. 4B with Fig. 2B). Furthermore,
co-expression of RhoGV12, RacL61 and Cdc42L61 failed to
recover the level of nocodazole-a¡ected uptake to the same
degree of rescue as that seen with Vav2 (Supplementary da-
ta1). As seen with the other GTPases, both variants of RhoG
localised to internalised bacteria (Fig. 4A and data not
shown). Taken together, our observations suggest a signalling
pathway where RhoG acts downstream of, or parallel to,
Vav2 and upstream of either Rac or Cdc42 but not both.
Nevertheless, the limited e¡ects of co-expressing activated
variants of Rac, Cdc42 and RhoG indicated that additional
factors, downstream of Vav2, were required for a complete
rescue.
One possible additional factor is RhoA, which can be acti-
vated by Vav2 and also through microtubule destabilisation
[32,34,40,41]. In accordance with reports by others, we ob-
served an increase in stress ¢bre formation in nocodazole-
treated cells, which would suggest upregulation of RhoA ac-
tivity (data not shown). Thus, we expressed GTPase-active
(GFP-RhoAV14) or GTPase-inactive (GFP-RhoAN19) var-
iants of RhoA and examined uptake in the presence of noco-
dazole. However, overexpression of either protein resulted in
partial rescue of bacterial uptake, where the inactive variant
was the more e⁄cient of the two in rescuing at the higher
drug concentration (Supplementary data1). As RhoA is
known to act antagonistically against Rac [42] the rescue
with the dominant negative protein could be explained by
Rac activation. This is consistent with a previous study dem-
onstrating inactivation of Rac but activation of RhoA as a
consequence of microtubule depolymerisation whereas the op-
posite result was observed when microtubules were allowed to
regrow [43]. We have previously seen that both the constitu-
tively active and dominant negative RhoA proteins generate a
repressive e¡ect on uptake as opposed to the stimulatory ef-
fect of activated Rac [4]. It is thus likely that phases of acti-
vation as well as inactivation of RhoA are in£uential in mod-
ulating uptake of Yersinia.
3.3. Disruption of the dynein^dynactin complex partially
suppresses invasin-mediated uptake but this e¡ect is
abrogated by co-expression of activated Vav2
Our data so far indicate a role for Vav2 in imitating the
e¡ect of microtubule involvement in directing actin dynamics
through Rho GTPases. Other factors which in£uence micro-
tubule function are microtubule motors. Puri¢ed phagosomes
have been shown to interact with microtubules in vitro and to
move on microtubules in a mainly minus-end directional and
dynein-dependent manner [44,45]. The dynein^microtubule in-
teraction is mediated by the dynactin complex, and disruption
of the dynein^dynactin interaction by expressing the p50 dy-
namitin subunit of dynactin inhibits dynein-dependent activity
[46].
Hence, to determine whether this motor is involved in in-
vasin-promoted uptake we co-expressed p50 dynamitin and a
GFP vector (as a marker for transfection) in HeLa cells and
analysed the e¡ect on uptake of Yersinia. In transfected cells
internalisation of bacteria was decreased by approximately
30% (uptake value; 70.5T 5.4%, n=4) compared to untrans-
fected cells. We have not yet pursued this aspect further,
therefore we can only speculate why dynein may be involved
in bacterial uptake. One possibility is that there may be micro-
tubule-dependent tra⁄cking, which may involve endocytosis
or exocytosis of a factor(s) participating in early events such
as integrin activation or clustering, or phagocytic cup forma-
tion. Indeed, microtubules and their motors have roles in
endocytic regulation [47]. Given the apparent involvement of
dynein we wondered whether upregulation of the actin cyto-
skeleton might overcome the e¡ect of disrupting dynein activ-
ity. We found that co-expressing v184N-Vav2-GFP with p50
dynamitin elevated uptake compared to cells expressing p50
dynamitin alone (Fig. 5). This further supports our hypothesis
that Vav2 can step in and assume control of GTPases when
the microtubule network is no longer functional.
This present work demonstrates that internalisation of
Y. pseudotuberculosis requires the integrity of the microtubule
cytoskeleton. Others have reported that Rho GTPases can
in£uence, or are in£uenced by, microtubule dynamics [25,26,
29,43]. Our data indicate that an intact microtubule network,
which implies a functional microtubule rail system, also con-
trols actin dynamics via Rho GTPases. We show that
GTPases and their regulators, such as the GEF Vav2, can
compensate for a disrupted microtubule function allowing
bacterial internalisation to occur. Many studies are currently
focused on unravelling the precise mechanism of cross-talk
between the actin and microtubule systems. We propose
Fig. 5. Activated Vav2 rescues the e¡ect of disruption of the dy-
nein^dynactin complex on invasin-mediated uptake. Uptake of
YPIII by nocodazole-treated HeLa cells co-expressing either p50 dy-
namitin and a GFP vector or p50 dynamitin and v184N-Vav2-
GFP. Internalisation of bacteria by transfected cells is normalised to
that of untransfected cells. Results are the meanTS.D. of four sepa-
rate experiments.
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that invasin-stimulated uptake can be used as a model system
to dissect signalling between Rho GTPases and the microtu-
bule and actin cytoskeleton networks.
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